These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24472478)

  • 81. Gemcitabine plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer.
    Dong N; Wu Y; Song C; Wang M; Jiao Y; Zhang S
    J BUON; 2020; 25(3):1348-1353. PubMed ID: 32862575
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical studies with epothilones for the treatment of metastatic breast cancer.
    Vahdat LT
    Semin Oncol; 2008 Apr; 35(2 Suppl 2):S22-30; quiz S40. PubMed ID: 18410796
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A phase I study of capecitabine combined with CPT-11 in metastatic breast cancer pretreated with anthracyclines and taxanes.
    Kashiwaba M; Inaba T; Komatsu H; Ishida K; Kawagishi R; Matsui Y; Uesugi N; Sugai T; Wakabayashi G
    Oncology; 2014; 86(4):206-11. PubMed ID: 24820348
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
    Huang H; Jiang Z; Wang T; Zhang S; Bian L; Cao Y; Wu S; Song S
    Anticancer Drugs; 2012 Aug; 23(7):718-23. PubMed ID: 22739713
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Gemcitabine/capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
    Andres R; Mayordomo JI; Lara R; Lastra R; Ortega E; Polo E; Lambea J; Isla D; Saenz-Cusi A; Escudero P; Tres A
    Clin Breast Cancer; 2005 Jun; 6(2):158-62. PubMed ID: 16001994
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [A pilot study of weekly versus 3-week docetaxel in combination with capecitabine in patients with anthracycline-pretreated metastatic breast cancer].
    Zhang SH; Jiang ZF; Xie XD; Wei Y; Ren J; Liu JW; Liu WC; Li X; Bai YX; Jiao SC; Sun Q; Liu DQ; Xiao JX; Wang HQ; Tang LL; Cheng Y; Wang Y; Wang YS
    Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(26):1813-5. PubMed ID: 20979824
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer.
    Lück HJ; Lübbe K; Reinisch M; Maass N; Feisel-Schwickardi G; Tomé O; Janni W; Aydogdu M; Neunhöffer T; Ober A; Aktas B; Park-Simon TW; Schumacher C; Höffkes HG; Illmer T; Wagner H; Mehta K; von Minckwitz G; Nekljudova V; Loibl S
    Breast Cancer Res Treat; 2015 Jan; 149(1):141-9. PubMed ID: 25519041
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Application of epothilones in breast cancer therapy.
    Cianfrocca M
    Curr Opin Oncol; 2008 Nov; 20(6):634-8. PubMed ID: 18841044
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients.
    Ozdemir N; Aksoy S; Sendur MA; Akinci MB; Yazici O; Budakoglu B; Abali H; Oksuzoglu B; Zengin N
    J BUON; 2013; 18(4):831-7. PubMed ID: 24344005
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?
    Levy C; Fumoleau P
    Cancer Treat Rev; 2005; 31 Suppl 4():S17-22. PubMed ID: 16360543
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients.
    Zelek L; Cottu P; Tubiana-Hulin M; Vannetzel JM; Chollet P; Misset JL; Chouaki N; Marty M; Gamelin E; Culine S; Dieras V; Mackenzie S; Spielmann M
    J Clin Oncol; 2002 May; 20(10):2551-8. PubMed ID: 12011135
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results.
    Michalaki V; Fotiou S; Gennatas S; Gennatas C
    Anticancer Res; 2010 Jul; 30(7):3051-4. PubMed ID: 20683054
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trial.
    Xu B; Sun T; Zhang Q; Zhang P; Yuan Z; Jiang Z; Wang X; Cui S; Teng Y; Hu XC; Yang J; Pan H; Tong Z; Li H; Yao Q; Wang Y; Yin Y; Sun P; Zheng H; Cheng J; Lu J; Zhang B; Geng C; Liu J; Shen K; Yu S; Li H; Tang L; Qiu R;
    Ann Oncol; 2021 Feb; 32(2):218-228. PubMed ID: 33188874
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer.
    Batista N; Perez-Manga G; Constenla M; Ruiz A; Carabantes F; Castellanos J; Gonzalez Barón M; Villman K; Söderberg M; Ahlgren J; Casinello J; Regueiro P; Murias A
    Br J Cancer; 2004 May; 90(9):1740-6. PubMed ID: 15150624
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial).
    Ciruelos EM; Cortés J; Cortés-Funes H; Mayordomo JI; Bermejo B; Ojeda B; García E; Rodríguez CA; Muñoz M; Gómez P; Manso L; Andrés R; Lluch A; Saura C; Mendiola C; Baselga J
    Ann Oncol; 2010 Jul; 21(7):1442-1447. PubMed ID: 19940004
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Implications of anthracycline-resistant and taxane-resistant metastatic breast cancer and new therapeutic options.
    Rivera E
    Breast J; 2010; 16(3):252-63. PubMed ID: 20408828
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: a single institution experience.
    Crivellari D; Spazzapan S; Lombardi D; Militello L; Torrisi E; Russo AE; Sorio R; Talamini R; Miolo G; Carli P; Veronesi A
    Tumori; 2012; 98(1):33-8. PubMed ID: 22495699
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer.
    Di Seri M; De Sanctis R; Quadrini S; Adua D; Stumbo L; Del Signore E; Gori B; Grassi P; Basile ML; Longo F
    J Chemother; 2011 Apr; 23(2):110-3. PubMed ID: 21571629
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparison between doublet agents versus single agent in metastatic breast cancer patients previously treated with an anthracycline and a taxane: a meta-analysis of four phase III trials.
    Qi WX; Tang LN; He AN; Shen Z; Yao Y
    Breast; 2013 Jun; 22(3):314-9. PubMed ID: 22901442
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane.
    Ahn JH; Kim SB; Kim TW; Ahn SH; Kim SM; Park JM; Lee JS; Kang YK; Kim WK
    J Korean Med Sci; 2004 Aug; 19(4):547-53. PubMed ID: 15308846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.